Company Filing History:
Years Active: 2010-2013
Title: Koichi Hasegawa: Innovator in Drug Safety
Introduction
Koichi Hasegawa is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of drug safety, particularly in assessing the risk of drug-induced granulocytopenia. With a total of 2 patents, Hasegawa's work is crucial for improving patient safety in pharmacology.
Latest Patents
Hasegawa's latest patents focus on methods for judging the risk of drug-induced granulocytopenia. One of his patents provides a means for determining the presence of this risk in humans. The method includes detecting a polymorphism of the human insulin receptor substrate-2 gene in a subject. By using this genetic polymorphism as an index, the presence of the risk of drug-induced granulocytopenia can be assessed effectively.
Career Highlights
Hasegawa is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of drug safety. His work is instrumental in developing safer pharmaceutical practices and enhancing the understanding of genetic factors in drug reactions.
Collaborations
Hasegawa collaborates with Koji Suematsu, a fellow innovator in the pharmaceutical industry. Their partnership aims to advance research and development in drug safety and efficacy.
Conclusion
Koichi Hasegawa's contributions to the field of drug safety through his innovative patents are vital for enhancing patient care. His work at Otsuka Pharmaceutical Company, Limited, along with his collaborations, continues to pave the way for safer pharmaceutical practices.